Compare RBB & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBB | MASS |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 441.7M | 498.1M |
| IPO Year | 2017 | 2020 |
| Metric | RBB | MASS |
|---|---|---|
| Price | $25.95 | $9.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $28.90 | $14.00 |
| AVG Volume (30 Days) | 85.2K | ★ 371.1K |
| Earning Date | 10-19-2026 | 11-10-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ 1.99 | N/A |
| Revenue | $5,167,000.00 | ★ $56,197,000.00 |
| Revenue This Year | $4.95 | $23.13 |
| Revenue Next Year | $2.10 | $18.66 |
| P/E Ratio | $13.04 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.45 | $5.03 |
| 52 Week High | $28.24 | $13.35 |
| Indicator | RBB | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 40.13 |
| Support Level | $25.50 | $9.32 |
| Resistance Level | $26.90 | $10.88 |
| Average True Range (ATR) | 0.56 | 0.93 |
| MACD | 0.01 | -0.20 |
| Stochastic Oscillator | 36.65 | 12.84 |
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.